| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 16.07B | 18.01B | 19.86B | 17.73B | 13.41B | 14.76B |
| Gross Profit | 2.03B | 2.40B | 2.60B | 2.04B | 1.82B | 1.74B |
| EBITDA | 633.78M | 785.73M | 882.88M | 770.47M | 707.32M | 640.99M |
| Net Income | -73.31M | 206.49M | 326.25M | 312.37M | 292.62M | 245.51M |
Balance Sheet | ||||||
| Total Assets | 8.23B | 9.26B | 9.48B | 9.56B | 8.03B | 7.92B |
| Cash, Cash Equivalents and Short-Term Investments | 1.33B | 1.09B | 1.11B | 1.39B | 1.79B | 1.79B |
| Total Debt | 2.22B | 2.28B | 2.31B | 2.34B | 2.09B | 2.39B |
| Total Liabilities | 5.52B | 6.09B | 6.30B | 6.59B | 5.33B | 5.38B |
| Stockholders Equity | 2.61B | 3.07B | 3.09B | 2.91B | 2.65B | 2.49B |
Cash Flow | ||||||
| Free Cash Flow | 413.75M | 367.73M | 491.67M | 257.42M | 564.89M | 348.09M |
| Operating Cash Flow | 628.26M | 582.03M | 722.02M | 451.77M | 727.77M | 529.11M |
| Investing Cash Flow | 603.76M | -338.14M | -525.29M | -867.43M | -391.52M | -319.50M |
| Financing Cash Flow | -476.82M | -180.89M | -472.75M | 21.49M | -256.63M | -15.46M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | £3.55B | 28.81 | 8.95% | 5.64% | 49.70% | -5.56% | |
70 Outperform | £4.40B | 26.07 | -3.13% | 14.05% | 41.95% | -140.18% | |
69 Neutral | £4.96B | -6.39 | -2.58% | 4.43% | -17.89% | -122.62% | |
69 Neutral | £5.33B | -136.53 | -4.05% | 8.77% | 57.55% | -54.80% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
65 Neutral | £62.49M | 23.11 | 6.02% | 6.59% | -5.21% | -33.93% | |
63 Neutral | £893.55M | 0.70 | 40.22% | 10.49% | ― | ― |